
CAS 489402-47-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
N-Mesitylbicyclo[2.2.1]Heptane-2-Carboxamide
CAS :N-Mesitylbicyclo[2.2.1]Heptane-2-CarboxamideDegré de pureté :95%Masse moléculaire :257.37g/molML213
CAS :ML213 (CID-3111211) is a selective activator of Kv7.2 (KCNQ2) and Kv7.4 (KCNQ4) channels, enhances Kv7.2 and Kv7.4 channels with EC50s of 230 and 510 nM,Formule :C17H23NODegré de pureté :>99.99%Couleur et forme :SolidMasse moléculaire :257.37N-Mesitylbicyclo[2.2.1]heptane-2-carboxamide
CAS :Formule :C17H23NODegré de pureté :98%Masse moléculaire :257.377ML-213
CAS :Produit contrôlé<p>Applications ML-213 is a selective KV7.2 (KCNQ2) and KV7.4 (KCNQ4) channel opener (EC50 values are 230 and 510 nM for KV7.2 and KV7.4 respectively). ML-213 displays >80-fold selectivity against KV7.1, KV7.3 and KV7.5 in a thallium-based fluorescence assay.<br>References Rundfeldt, C., et al.: Eur. J. Pharmacol., 336, 243 (1997); Singh, N., et al.: Brain, 126, 2726 (2003); Munro, G., et al.: J. Med. Chem., 50, 2576 (2007); Qi, J., et al.: Eur. J. Med. Chem., 46, 934 (2011);<br></p>Formule :C17H23NOCouleur et forme :NeatMasse moléculaire :257.371ML-213
CAS :<p>ML-213 is a cationic, non-selective drug that is membrane hyperpolarizing. It has been shown to increase the intracellular Ca2+ concentration in cells and to inhibit the growth of human liver, bladder, and mesenteric cells. ML-213 also exhibits selective activities against human lung cancer cells in vitro. It binds to DNA polymerase, preventing transcription and replication. This drug also inhibits the activity of protein kinases by binding to their ATP binding site. The conformational properties of ML-213 have been studied using NMR spectroscopy and found to be affected by alcohol exposure.</p>Formule :C17H23NODegré de pureté :Min. 95%Masse moléculaire :257.37 g/mol





